Viewing data from:

DIMENHYDRINATE

ANDA

DIMENHYDRINATE | A084767 | BAXTER HEALTHCARE CORP ANESTHESIA AND CRITICAL CARE

1 strength0 unique patents0 unique exclusivities

Medicare Part B Spending

CMS physician-administered drug spending for Dimenhydrinate (2023)

Total Spending

$5K

Total Claims

527

Beneficiaries

224

ASP Price

—

HCPCS: J1240 — Injection, dimenhydrinate, up to 50 mg

Source: CMS Medicare Part B Spending by Drug (2023). Shows physician-administered drug costs.

API Supply Chain2 active DMFs1 inactive

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPADIMENHYDRINATE

DMF 46271982

SHANGHAI WONDER PHARMACEUTICAL CO LTDDIMENHYDRINATE

DMF 313532017

KNOLL AG LUDWIGSHAFENInactiveDIMENHYDRINATE

DMF 46151982

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 50MG/ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.